These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32202053)

  • 1. Novel volumetric analysis for stent expansion after drug-eluting stent implantation: An optical coherence tomography study.
    Katsura A; Minami Y; Kato A; Muramatsu Y; Sato T; Hashimoto T; Meguro K; Shimohama T; Ako J
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):E501-E507. PubMed ID: 32202053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN I Substudy.
    Nakamura D; Wijns W; Price MJ; Jones MR; Barbato E; Akasaka T; Lee SW; Patel SM; Nishino S; Wang W; Gopinath A; Attizzani GF; Holmes D; Bezerra HG
    JACC Cardiovasc Interv; 2018 Aug; 11(15):1467-1478. PubMed ID: 30093052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight to estimate under-expansion after stent implantation on bifurcation lesions using optical coherence tomography.
    Nakamura D; Attizzani GF; Nishino S; Tanaka K; Soud M; Pereira GT; Leygerman M; Fares A; Schnell A; Costa MA; Erglis A; Bezerra HG
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1677-1684. PubMed ID: 28597125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of a new optical coherence tomography-derived volumetric method for evaluating stent expansion.
    Kawamura A; Nakamura D; Shutta R; Nakamura H; Matsuhiro Y; Okamoto N; Egami Y; Sakata Y; Nishino M; Tanouchi J
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1121-1129. PubMed ID: 33123936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.
    Muramatsu T; Ozaki Y; Nanasato M; Ishikawa M; Nagasaka R; Ohota M; Hashimoto Y; Yoshiki Y; Takatsu H; Ito K; Kamiya H; Yoshida Y; Murohara T; Izawa H;
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009314. PubMed ID: 33106049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
    Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serial optical coherence tomography imaging following aggressive stent expansion technique: insight from the MECHANISM study.
    Sasaki W; Ishida M; Itoh T; Uchimura Y; Oda H; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Terashita D; Otake H; Shinke T; Morino Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):419-428. PubMed ID: 33034867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Stent Expansion Using a Volumetric Versus the Conventional Method Through Optical Coherence Tomography in an All-Comers Population.
    Dallan LAP; Pereira GTR; Zimin V; Zago EI; Vergara-Martel A; Fares A; Bezerra HG
    Cardiovasc Revasc Med; 2021 Mar; 24():48-54. PubMed ID: 32981855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lesion angle on optical coherence tomography findings and clinical outcomes after drug-eluting stent implantation in curved vessels.
    Nakamura S; Kimura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hishikari K; Hikita H; Takahashi A; Hirao K
    Int J Cardiovasc Imaging; 2019 Dec; 35(12):2147-2155. PubMed ID: 31359232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.
    Kim BG; Kachel M; Kim JS; Guagliumi G; Kim C; Kim IS; Lee YJ; Lee OH; Byun YS; Kim BO; Milewski K; Lee SJ; Hong SJ; Ahn CM; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2022 Jan; 15(1):126-137. PubMed ID: 34023255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Follow-Up Optical Coherence Tomographic Findings of Significant Drug-Eluting Stent Malapposition.
    Lee SY; Ahn CM; Yoon HJ; Hur SH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007192. PubMed ID: 30562088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study.
    Worthley SG; Abizaid A; Kirtane AJ; Simon DI; Windecker S; Brar S; Meredith IT; Shetty S; Sinhal A; Almonacid AP; Chamié D; Maehara A; Stone GW;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):147-156. PubMed ID: 28104208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.